8-K
filed January 19, 2023, 6:59 PM ET
ticker ISRLF
CIK 0001915328
other material
confidence high
sentiment neutral
materiality 0.40
Israel Acquisitions Corp closes $143.75M IPO including full over-allotment
Israel Acquisitions Corp
- Priced 14.375M units at $10.00 each on Jan. 13, 2023; gross proceeds $143.75M.
- Over-allotment fully exercised: additional 1.875M units raised $18.75M.
- Simultaneous private placement of 762.5K units to sponsor & underwriters for $7.625M.
- Total $146.625M deposited into trust account at J.P. Morgan Chase.
- Board appointed: Izhar Shay, Ziv Elul, Sharon Barzik Cohen plus five independent directors.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sharon Barzik Cohen was appointed as Director at Israel Acquisitions Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Daniel Recanati was appointed as Director at Israel Acquisitions Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Izhar Shay was appointed as Director at Israel Acquisitions Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Roy Zisapel was appointed as Director at Israel Acquisitions Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ziv Elul was appointed as Director at Israel Acquisitions Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Peter Cohen was appointed as Director at Israel Acquisitions Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Candice Beaumont was appointed as Director at Israel Acquisitions Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
On January 12, 2023, in connection with the IPO, Izhar Shay, Candice Beaumont, Peter Cohen, Roy Zisapel and Daniel Recanati (together with Ziv Elul and Sharon Barzik Cohen, the “Directors”) were each appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.